AgomAb Therapeutics NV (AGMB)
NASDAQ: AGMB · Real-Time Price · USD
10.49
+0.63 (6.39%)
Mar 31, 2026, 4:00 PM EDT - Market closed
AgomAb Therapeutics NV Market Cap
AgomAb Therapeutics NV has a market cap or net worth of $511.25 million as of April 1, 2026.
Market Cap
511.25M
Enterprise Value
360.76M
1-Year Change
n/a
Ranking
Category
Stock Price
$10.49
Market Cap Chart
Since the IPO on February 6, 2026, AgomAb Therapeutics NV's market cap has decreased from $779.79M to $511.25M, a decrease of -34.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 511.25M | 6.39% |
| Mar 30, 2026 | 480.54M | -9.12% |
| Mar 27, 2026 | 528.79M | -8.59% |
| Mar 26, 2026 | 578.51M | -7.70% |
| Mar 25, 2026 | 626.75M | 10.43% |
| Mar 24, 2026 | 567.54M | -4.94% |
| Mar 23, 2026 | 597.03M | 0.49% |
| Mar 20, 2026 | 594.10M | -4.02% |
| Mar 19, 2026 | 618.96M | -8.30% |
| Mar 18, 2026 | 675.00M | 1.02% |
| Mar 17, 2026 | 668.18M | -4.23% |
| Mar 16, 2026 | 697.67M | 3.36% |
| Mar 13, 2026 | 675.00M | -0.43% |
| Mar 12, 2026 | 677.93M | 2.51% |
| Mar 11, 2026 | 661.36M | -1.31% |
| Mar 10, 2026 | 670.13M | -4.71% |
| Mar 9, 2026 | 703.27M | 5.95% |
| Mar 6, 2026 | 663.79M | -4.15% |
| Mar 5, 2026 | 692.55M | -3.20% |
| Mar 4, 2026 | 715.46M | -7.67% |
| Mar 3, 2026 | 774.91M | -1.91% |
| Mar 2, 2026 | 790.02M | 1.19% |
| Feb 27, 2026 | 780.76M | 0.06% |
| Feb 26, 2026 | 780.28M | -0.62% |
| Feb 25, 2026 | 785.15M | 0.75% |
| Feb 24, 2026 | 779.30M | 3.83% |
| Feb 23, 2026 | 750.55M | -0.65% |
| Feb 20, 2026 | 755.42M | -0.70% |
| Feb 19, 2026 | 760.78M | 6.19% |
| Feb 18, 2026 | 716.43M | -2.97% |
| Feb 17, 2026 | 738.36M | -1.24% |
| Feb 13, 2026 | 747.62M | -2.04% |
| Feb 12, 2026 | 763.22M | -2.13% |
| Feb 11, 2026 | 779.79M | 2.89% |
| Feb 10, 2026 | 757.86M | -0.38% |
| Feb 9, 2026 | 760.78M | -2.44% |
| Feb 6, 2026 | 779.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prothena Corporation | 497.96M |
| ProKidney | 489.10M |
| Aclaris Therapeutics | 485.09M |
| Upstream Bio | 477.81M |
| Rigel Pharmaceuticals | 475.13M |
| Forte Biosciences | 469.32M |
| Contineum Therapeutics | 465.21M |
| ADC Therapeutics | 462.44M |